User:Mcfall2016/sandbox

From Wikipedia, the free encyclopedia

Sounds good, make sure you tie in a biophysical role. DJW56 (talk) 05:24, 9 October 2016 (UTC)

<nowiki>Where do you have your updates or your draft of the page? I am looking to do the peer review. Trb9 (talk) 22:02, 5 November 2016 (UTC)


Transport[edit]

Free Hormone Hypothesis 2

Steroid hormones are transported through the blood by being bound to carrier proteins--serum proteins that bind them and increase the hormones' solubility in water. Some examples are sex hormone-binding globulin (SHBG), corticosteroid-binding globulin, and albumin.[1] Most studies say that hormones can only affect cells when they are not bound by serum proteins. In order to be active, steroid hormones must free themselves from their blood-solubilizing proteins and either bind to extracellular receptors, or passively cross the cell membrane and bind to nuclear receptors. This idea is known as the free hormone hypothesis. This idea is shown in Figure 1 to the right.

This shows a possible pathway through which steroid hormones are endocytosed and proceed to affect cells via a genomic pathway.

One study has found that these steroid-carrier complexes are bound by megalin, a membrane receptor, and are then taken into cells via endocytosis. One possible pathway is that once inside the cell these complexes are taken to the lysosome, where the carrier protein is degraded and the steroid hormone is released into the cytoplasm of the target cell. The hormone then follows a genomic pathway of action. This process is shown in Figure 2 to the right. [2] The role of endocytosis in steroid hormone transport is not well understood and is under further investigation.

In order for steroid hormones to cross the lipid bilayer of cells they must overcome energetic barriers that would prevent their entering or exiting the membrane. Gibbs free energy is an important concept here. These hormones, which are all derived from cholesterol, have hydrophilic functional groups at either end and hydrophobic carbon backbones. When steroid hormones are entering membranes free energy barriers exist when the functional groups are entering the hydrophobic interior of membrane, but it is energetically favorable for the hydrophobic core of these hormones to enter lipid bilayers. These energy barriers and wells are reversed for hormones exiting membranes. Steroid hormones easily enter and exit the membrane at physiologic conditions. They have been shown experimentally to cross membranes near a rate of 20 μm/s, depending on the hormone. [3]

Though it is energetically more favorable for hormones to be in the membrane than in the ECF or ICF, they do in fact leave the membrane once they have entered it. This is an important consideration because cholesterol--the precursor to all steroid hormones--does not leave the membrane once it has embedded itself inside. The difference between cholesterol and these hormones is that cholesterol is in a much larger negative Gibb's free energy well once inside the membrane, as compared to these hormones. This is because the carbohydrate tail on cholesterol has a very favorable interaction with the interior of lipid bilayers. [3]


Mechanisms of Action and Effects[edit]

There are many different mechanisms through which steroid hormones affect their target cells. All of these different pathways can be classified as having either a genomic effect or a non-genomic effect. Genomic pathways are slow and result in altering transcription levels of certain proteins in the cell; non-genomic pathways are much faster.


Genomic Pathways[edit]

The first identified mechanisms of steroid hormone action were the genomic effects.[4] In this pathway, the free hormones first pass through the cell membrane because they are fat soluble.[5] In the cytoplasm, the steroid may or may not undergo an enzyme-mediated alteration such as reduction, hydroxylation, or aromatization. Also in the cytoplasm, the steroid binds to a specific steroid hormone receptor, also known as a nuclear receptor, which is a large metalloprotein. Upon steroid binding, many kinds of steroid receptors dimerize: two receptor subunits join together to form one functional DNA-binding unit that can enter the cell nucleus. Once in the nucleus, the steroid-receptor ligand complex binds to specific DNA sequences and induces transcription of its target genes.[6][7][4]


Non-genomic Pathways[edit]

Because non-genomic pathways include any mechanism that is not a genomic effect, there are various non-genomic pathways. However, all of these pathways are mediated by some type of receptor found at the plasma membrane. [8]. Ion channels, transporters, G protein-coupled receptors (GPCR), and membrane fluidity have all been shown to be affected by steroid hormones. [3] Of these, GPCR linked proteins are the most common.


GPCR linked proteins most likely interact with steroid hormones through an amino acid consensus sequence traditionally thought of as a cholesterol recognition and interaction site. About a third of Class A GPCRs contain this sequence. The steroid hormones themselves are different enough from one another that they do not all affect all of the GPCR linked proteins; however, the similarities between the steroid hormones and between the receptors make plausible the argument that each receptor may respond to multiple steroid hormones or that each hormone could affect multiple receptors. This is contrary to the traditional model of having a unique receptor for each unique ligand.[8]


At least four different GPCR-linked proteins are known to respond to steroid hormones. G Protein-Coupled Receptor 30 (GPR30) binds estrogen, Membrane Progestin Receptor (mPR) binds progesterone, G Protein-Coupled Receptor Family C Group 6 Member A (GPRC6A) binds androgens, and Trace Amine Associated Receptor 1 (TAAR1) binds Thyroid hormone (though not technically steroid hormones, thyroid hormones can be grouped here because their receptors belong to the nuclear receptor superfamily). As an example of the effects of these GPCR-linked proteins consider GPR30. GPR30 binds estrogen, and upon binding estrogen this pathway activates adenylyl cyclase and epidermal growth factor receptor. It results in vasodilation, renoprotection, mammary gland development, etc. [8]

  1. ^ Adams, John S. 2005. "Bound" to work: The free hormone hypothesis revisited. Cell 122 (5): 647-9.
  2. ^ Hammes, A. 2005. Role of endocytosis in cellular uptake of sex steroids. Cell 122 (5): 751-62.
  3. ^ a b c Oren, Idit. 2004. Free diffusion of steroid hormones across biomembranes: A simplex search with implicit solvent model calculations. Biophysical Journal 87 (2): 768-79.
  4. ^ a b Rousseau, Guy. 2013. Fifty years ago: The quest for steroid hormone receptors. Molecular and Cellular Endocrinology 375 (1-2): 10-3.
  5. ^ Linda J. Heffner; Danny J. Schust (2010). The Reproductive System at a Glance. John Wiley and Sons. pp. 16–. ISBN 978-1-4051-9452-5. Retrieved 28 November 2010.
  6. ^ Moore FL, Evans SJ (1995). "Steroid hormones use non-genomic mechanisms to control brain functions and behaviors: a review of evidence". Brain Behav Evol. 51 (4): 41–50. PMID 10516403.
  7. ^ Marcinkowska E, Wiedłocha A (2002). "Steroid signal transduction activated at the cell membrane: from plants to animals". Acta Biochim Pol. 43 (9): 735–745. PMID 12422243.
  8. ^ a b c Wang, Chen, Yi Liu, and Ji-Min Cao. 2014. G protein-coupled receptors: Extranuclear mediators for the non-genomic actions of steroids. International Journal of Molecular Sciences 15 (9): 15412-25.